Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Tina-quant C-Reactive Protein IV

K-Number: K192072 · 2020-02-21

Decision Date2020-02-21
Product CodeDCN
Advisory CommitteeIM
DecisionSubstantially Equivalent

Device Summary

Tina-quant C-Reactive Protein IV is a medical device manufactured by Roche Diagnostics Operations (Rdo). It received FDA 510(k) clearance on 2020-02-21 under approval number K192072. The device is classified under product code DCN. It was reviewed by the IM advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Tina-quant C-Reactive Protein IV?

Tina-quant C-Reactive Protein IV is a medical device that received FDA 510(k) clearance on 2020-02-21. It is manufactured by Roche Diagnostics Operations (Rdo). The 510(k) number is K192072.

When was Tina-quant C-Reactive Protein IV approved by the FDA?

Tina-quant C-Reactive Protein IV received FDA 510(k) clearance on 2020-02-21, under approval number K192072.

What company makes Tina-quant C-Reactive Protein IV?

Tina-quant C-Reactive Protein IV is manufactured by Roche Diagnostics Operations (Rdo).

What is the FDA product code for Tina-quant C-Reactive Protein IV?

The FDA product code for Tina-quant C-Reactive Protein IV is DCN.

Related Clinical Trials

Other Devices by Roche Diagnostics Operations (Rdo)

View all 10 devices →

Related Devices (Code: DCN)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.